FDA
-
-
-
-
-
-
-
Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19
-
-
-
-
-
-
-
Statera Biopharma, Inc., Announces Central Institutional Review Board Approval of Phase 3 Clinical Trial for Pediatric Crohn’s Disease
-
-
-
-
-
-
-
Statera Biopharma Honors Pancreatic Cancer Awareness Month
-
322,647 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

